NEU 6.41% $15.27 neuren pharmaceuticals limited

Share Price, page-11398

  1. 1,761 Posts.
    lightbulb Created with Sketch. 203
    In response to pfuzzy

    I am assuming 5 percent QoQ growth (20% annual) - very achievable in the US alone, let alone with RoW coming online which should replace the growth when the US slows. We have 220m in cash, 33m PRV (our share), and 77m one-off for sales milestone. When you subtract that Daybue (our share) and NNZ-2591 combined implied value is 1.63b AUD or about 1bn USD.Using low end of the guidance (55m AUD) multiplied by a 35 multiplier you could get 1.95B AUD for our share of Daybue alone. 35 is a reasonable multiplier for an income stream like that which is growing at 20% annually. Either way, you could use a lesser multiple and still get to that figure.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.